We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 130

Michigan Strikes Back . . . In Pennsylvania
  • Reed Smith LLP
  • USA
  • December 15 2017

A (relatively) long time ago in a state not so far away, the Michigan Legislature enacted the Michigan Product Liability Act. It contained a

Michigan Court Excludes Expert Testimony from Treater and Grants Summary Judgment
  • Dechert LLP
  • USA
  • July 20 2017

Usually when we are talking about Michigan, it's to praise the Michigan Products Liability Act which cuts off civil liability for drug manufacturers

Plaintiffs’ Fraud-On-The-FDA Claim Preempted By Federal Law
  • Weil Gotshal & Manges LLP
  • USA
  • September 21 2016

Last month, a West Virginia state judge granted summary judgment for Pfizer on the basis that the manufacturer was immune from suit pursuant to

Michigan craft brewers beware: FDA labeling rule may impact your business
  • Morsel Law
  • USA
  • April 24 2015

Over the past two years Michigan business owners spent considerable time implementing procedures to comply with the health care requirements under

Mateveza makes sure its "baby" isn't thrown out with alcohol energy drinks
  • Davis Wright Tremaine LLP
  • USA
  • November 5 2010

Mateveza (an organic, naturally caffeinated beer) responded quickly to the State of Michigan's efforts to ban "alcohol energy drinks" from the market.

Michigan bans alcoholic energy drinks, Pennsylvania requests removal
  • Shook Hardy & Bacon LLP
  • USA
  • November 5 2010

The Michigan Liquor Control Commission (MLCC) has rescinded "the approval of all alcohol energy drinks AEDs," citing "widespread community concerns aired by substance abuse prevention groups, parent groups and various members of the public, as well as the Food and Drug Administration's (FDA's) decision to further investigate these products."

AnnMarie Sanford
  • Pepper Hamilton LLP